103 related articles for article (PubMed ID: 2126027)
21. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice.
Arika T; Amemiya K; Nomoto K
Biotherapy; 1992; 4(2):165-70. PubMed ID: 1622736
[TBL] [Abstract][Full Text] [Related]
22. [Two color analysis of peripheral lymphocyte subsets in patients with cancers during and after radiotherapy].
Nakatsugawa S; Kimoto T; Takahashi N; Kimura H; Takabatake M; Yamada H; Maeda M; Yamamoto K; Suto Y; Kimura K
Gan No Rinsho; 1988 Oct; 34(13):1789-98. PubMed ID: 3264350
[TBL] [Abstract][Full Text] [Related]
23. Multidisciplinary treatment for bladder carcinoma--biological response modifiers and kampo medicines.
Horii A; Kyo M; Asakawa M; Yasumoto R; Maekawa M
Urol Int; 1991; 47 Suppl 1():108-12. PubMed ID: 1949364
[TBL] [Abstract][Full Text] [Related]
24. Improvement of long-term prognosis in patients with ovarian cancers by adjuvant sizofiran immunotherapy: a prospective randomized controlled study.
Inoue M; Tanaka Y; Sugita N; Yamasaki M; Yamanaka T; Minagawa J; Nakamuro K; Tani T; Okudaira Y; Karita T
Biotherapy; 1993; 6(1):13-8. PubMed ID: 8507540
[TBL] [Abstract][Full Text] [Related]
25. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer.
Shimizu Y; Hasumi K; Masubuchi K
Cancer; 1992 Mar; 69(5):1184-94. PubMed ID: 1739919
[TBL] [Abstract][Full Text] [Related]
26. [Clinical efficacies of schizophyllan (SPG) on advanced gastric cancer].
Fujimoto S
Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1447-50. PubMed ID: 2531270
[TBL] [Abstract][Full Text] [Related]
27. Impact of radiotherapy with and without concurrent cisplatin on lymphocyte subpopulations in cervical cancer patients.
Bachtiary B; Herbacek I; Zideck T; Knocke TH; Dimopoulos J; Poetter R; Micksche M
Anticancer Res; 2005; 25(6C):4673-8. PubMed ID: 16334159
[TBL] [Abstract][Full Text] [Related]
28. [Combination therapy of radiation and schizophyllan (SPG) in C3H mouse squamous-cell carcinoma NR-S1].
Arika T; Amemiya K; Mochizuki S
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2841-7. PubMed ID: 2944485
[TBL] [Abstract][Full Text] [Related]
29. [Two cases of cancer with bone metastases treated with local therapy].
Kurokawa T; Tamakuma S
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1717-9. PubMed ID: 8373257
[TBL] [Abstract][Full Text] [Related]
30. The impact of squamous cell carcinoma (SCC) antigen in patients with advanced cancer of uterine cervix treated with (chemo-)radiotherapy.
Micke O; Bruns F; Schäfer U; Prott FJ; Willich N
Anticancer Res; 2005; 25(3A):1663-6. PubMed ID: 16033078
[TBL] [Abstract][Full Text] [Related]
31. The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.
Mizunuma M; Yokoyama Y; Futagami M; Aoki M; Takai Y; Mizunuma H
Int J Clin Oncol; 2015 Oct; 20(5):989-96. PubMed ID: 25736530
[TBL] [Abstract][Full Text] [Related]
32. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
[TBL] [Abstract][Full Text] [Related]
33. Immunological status in cervical cancer in relation to pelvic irradiation.
Chandra M; Chander S
Indian J Med Res; 1986 Oct; 84():413-7. PubMed ID: 3781598
[No Abstract] [Full Text] [Related]
34. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
35. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
[TBL] [Abstract][Full Text] [Related]
36. [Clinical evaluation of schizophyllan (SPG) in advanced gastric cancer--a randomized comparative study by an envelope method].
Nakao I; Uchino H; Orita K; Kaido I; Kimura T; Goto Y; Kondo T; Takino T; Taguchi T; Nakajima T; Fujimoto S; Miyazaki T; Miyoshi A; Yachi A; Yoshida K; Ogawa N; Furue H
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1146-59. PubMed ID: 6223584
[TBL] [Abstract][Full Text] [Related]
37. [Study on the TIL and NK of IL-2 injected via pelvic retroperitoneal space in gynecological cancer patient].
Chen J; Cao ZY; Zhang P; Peng ZL; Yang YL; Bi JH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):406-8. PubMed ID: 15181850
[TBL] [Abstract][Full Text] [Related]
38. Natural killer cells and interleukin-12 in patients with advanced cervical cancer under neoadjuvant chemotherapy.
Marana HR; Andrade JM; Silva JS
Braz J Med Biol Res; 1996 Apr; 29(4):473-7. PubMed ID: 8736110
[TBL] [Abstract][Full Text] [Related]
39. Changes in natural killer cell activity by external radiotherapy and/or brachytherapy.
Yamazaki H; Yoshioka Y; Inoue T; Tanaka E; Nishikubo M; Sato T; Ishida T; Nakamura H; Inoue T
Oncol Rep; 2002; 9(2):359-63. PubMed ID: 11836608
[TBL] [Abstract][Full Text] [Related]
40. Increased natural killer cell activity in uterine cervix cancer patients undergoing radiation therapy.
Pinel MI; Esteves EB; Rumjanek VM
Nat Immun; 1995 Apr; 14(4):216-24. PubMed ID: 8696011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
